This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

News
22 Sep 2021

Abdi İbrahim wins two more international awards

Active for 109 years in the pharmaceutical industry with the goal of healing life, Abdi İbrahim continues to crown its accomplishments internationally in management and public relations projects. Abdi İbrahim has won two bronze awards by one of the most prestigious business award platforms in the world, the Stevie International Business Awards. 

As a company that has consecutively led the Turkish pharma industry for the last 19 years and has strengthened its global position by entering a strategic partnership with the Swiss biopharma company OM Pharma in September 2020, Abdi Ibrahim continues its success, both in the domestic and the international arena. This year, Abdi Ibrahim has been granted two bronze awards by the US-based Stevie International Business Awards.

The Stevie International Business Awards, which selects from a pool of applications made in different project categories by prominent international companies, has granted Abdi Ibrahim’s Chairman Nezih Barut a bronze award in the “Chairman of the Year” category. The judging committee chose the winners based on their leadership and their company’s success since 2019.

Among the accomplishments for which Nezih Barut was awarded a Stevie Award in the Chairman of the Year category were his proactive decisions with regards to the medication used for the treatment of COVID-19, his decision to quickly manufacture and donate to the Ministry of Health the medication that was available throughout the world and that was part of the initial treatment protocol, the investments made in biotechnology, an area that is gaining more prominence every year, as it helps treat diseases that are otherwise not treatable by medicinal chemistry, Abdi Ibrahim’s performance in sustainability and fight against climate change, as proven by being the first pharma company in Turkey to publicly announce its goal to go carbon neutral by 2030 in line with the Paris Climate Agreement, and the company’s 2020 investment in the Swiss biopharma company OM Pharma through a Swiss joint venture, which gave them 28.5% share ownership and led Abdi Ibrahim to become the first and only Turkish company to have a strategic partnership with a European company. In addition to his role as the Chairman of the Board at Abdi Ibrahim, Nezih Barut has also been serving as the Chairman of Pharmaceutical Manufacturers Association of Turkey (İEİS) for the last 13 years.

 Abdi Ibrahim’s “Viral Agenda”, a project through which much-needed current and evidence-based medical information is shared with the public during the pandemic, was given a bronze award in the “Communications/PR Campaign of the Year- COVID-19 Related Information (in the “COVID-19 Response” category). 

Award Winning Project “Viral Agenda” provides accurate information on COVID-19

Launched in 2002, the Stevie International Business Awards receive over 12 thousand applications from persons/companies/projects/campaigns in 8 categories and their sub-categories. This year, Abdi Ibrahim has received two awards after being evaluated by a committee composed of 260 industry professionals.

The Viral Agenda communication project, which won the bronze award in the Communications/PR Campaign of the Year category, was initiated to stop the spread of  misinformation and provide accurate information. The project involved scanning through hundreds of articles published around the world with the aim of providing updated and reliable information weekly on COVID-19, first to doctors and other health workers, and then to the general public, using simpler terms. The Viral Agenda was prepared by a group of doctors from different specialization fields, working under Abdi Ibrahim’s Medical Directorate, and it was communicated to the 4600 employees of the company and the target audience on a weekly basis through e-mail, LinkedIn, Twitter, Facebook and Instagram accounts. Through this project, the spread of unscientific or unverified information was stopped



For information: 

Hill + Knowlton Strategies – +90 212 270 52 32 

Burcu Yakar: Media Director- +90 532 779 30 18 / [email protected] 

Mustafa Salih: Media Director- +90 536 863 19 04 / [email protected]

 

 

Mentioned Companies
ABDI IBRAHIM ILAC SAN. VE TIC. A.S.
View company profile